Associate Director, New Product Planning & Compound Strategy, Lung Cancer and Companion Diagnostics, Japan
Revolution Medicines · Tokyo, Japan
Posted about 2 months ago
or apply directly on Revolution Medicines's site. We never take the application ourselves.
Is this posting real?
- This role has been open
- 64 days Revolution Medicines's roles stay open a median of 78 days
- Reposted
- No
- Salary listed
- No 0% of Revolution Medicines's roles list one
- Ghost-job risk at Revolution Medicines
- high 259 stale, 6 reposted of 264 open
- Hiring momentum
- 449 roles opened in the last 90 days ↑ up vs. the prior 90 days
- Last confirmed on the employer's board
- 2026-10-22
Measured from postings appearing on and disappearing from Revolution Medicines's own greenhouse board since 2026-08-03. Full hiring picture for Revolution Medicines.
About this role
The Associate Director, New Product Planning & Compound Strategy will lead the commercial strategy for Revolution Medicines' lung cancer pipeline in Japan. This role involves developing integrated strategies for compound and new product planning, collaborating with various teams to ensure successful commercialization of oncology therapies, and managing companion diagnostics strategies. The position requires a strong understanding of the oncology ecosystem and the ability to influence cross-functional teams to achieve launch readiness and long-term success.
- benefits
- 1/5
- freshness
- 4/5
- career value
- 4/5
- role clarity
- 5/5
- pay transparency
- 0/5
Scored from the posting itself — how clearly the role is described, how much it says about pay and benefits, and how recently it was listed. Not a judgement of Revolution Medicines as an employer.
What you need
- Bachelor's degree required
- Minimum of 10 years of progressive pharmaceutical and/or biotechnology commercial experience required
- Minimum of 3 years of Oncology Marketing, New Product Planning, Early Commercial, or Commercial Strategy experience required
- Demonstrated experience in Companion Diagnostics (CDx), biomarker-driven oncology, or precision medicine required
- Proven product launch experience required
- Strong understanding of the oncology ecosystem, including patients, healthcare professionals, institutions, payers, diagnostic stakeholders, and biomarker testing pathways
Nice to have
- Advanced degree (MBA, PharmD, PhD, MSc, or equivalent) preferred
- Demonstrated experience developing compound strategies, commercial assessments, portfolio strategies, lifecycle management, or launch strategies for pipeline assets preferred
- Entrepreneurial mindset with the ability to thrive in a dynamic, fast-growing biotechnology environment
Worth weighing
- No salary listed
- Role involves significant cross-functional collaboration and influence without direct authority
- Focus on oncology and precision medicine may require specialized knowledge
- Position is based in Tokyo, Japan, which may affect relocation considerations
Summarised from Revolution Medicines's posting. Read the full original.
Listed by Revolution Medicines on their greenhouse job board, last confirmed open on 2026-10-22. PitchMeAI is not the employer.
More roles at Revolution Medicines
- Manager, Legal OperationsRedwood City, California, United States
- Associate Director, Global Regulatory Affairs Project ManagementRedwood City, California, United States
- Senior Safety Scientist IIRedwood City, California, United States
- Principal Statistical AnalystRedwood City, California, United States
- Application Administrator IIRedwood City, California, United States
- Director, Senior Corporate Counsel, GermanyMunich, Germany
- Executive Director, Clinical DevelopmentRedwood City, California, United States
- Senior Manager, Commercial Supply ChainRedwood City, California, United States